Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis

[1]  G. McHugh,et al.  Adherence to additional medication for management of HIV-associated comorbidities among older children and adolescents taking antiretroviral therapy , 2022, PloS one.

[2]  S. Rowland-Jones,et al.  Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease , 2020, JAMA network open.

[3]  Mireille Porter,et al.  Not yet 90-90-90: A quality improvement approach to human immunodeficiency virus viral suppression in paediatric patients in the rural Eastern Cape, South Africa , 2020, South African family practice : official journal of the South African Academy of Family Practice/Primary Care.

[4]  G. McHugh,et al.  Chronic lung disease in children and adolescents with HIV: a case–control study , 2020, Tropical medicine & international health : TM & IH.

[5]  S. Rowland-Jones,et al.  Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial , 2017, Trials.

[6]  A. Harries,et al.  High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015 , 2017, PloS one.

[7]  S. Rowland-Jones,et al.  Chronic lung disease in HIV-infected children established on antiretroviral therapy , 2016, AIDS.

[8]  B. Walker,et al.  Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe , 2015, PloS one.

[9]  L. Cluver,et al.  Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low- and middle-income countries: a systematic review , 2015, AIDS care.

[10]  Art-Cc.  Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients , 2015 .

[11]  E. Goemaere,et al.  Paediatric HIV treatment failure: a silent epidemic , 2015, Journal of the International AIDS Society.

[12]  C. Yiannoutsos,et al.  Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa , 2014, AIDS.

[13]  A. Calmy,et al.  Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa — A Systematic Review and Meta-Analysis , 2013, PloS one.

[14]  S. Reid,et al.  Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. , 2010, The Lancet. Infectious diseases.

[15]  D. Taddeo,et al.  Adherence to treatment in adolescents. , 2008, Paediatrics & child health.

[16]  J. Henzen.  Publisher's note , 1979, Brain Research.